147 related articles for article (PubMed ID: 38686412)
1. [Computer-aided prediction and molecular mechanism investigation of active components in compound Kushen injection inhibiting p21-activated kinase 1].
Lin L; Chang J; Tian Y; Chen J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2024 Apr; 41(2):313-320. PubMed ID: 38686412
[TBL] [Abstract][Full Text] [Related]
2. Natural Compound Shikonin Is a Novel PAK1 Inhibitor and Enhances Efficacy of Chemotherapy against Pancreatic Cancer Cells.
Ji W; Sun X; Gao Y; Lu M; Zhu L; Wang D; Hu C; Chen J; Cao P
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566098
[TBL] [Abstract][Full Text] [Related]
3. [Identification of potential targets and synergistic mechanism of Kushen Decoction for the treatment of cryptosporidiosis].
Zhan N; Liu XH; Tang FY; Zhang JY
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2021 Oct; 33(5):483-495. PubMed ID: 34791846
[TBL] [Abstract][Full Text] [Related]
4. Molecular modelling approaches predicted 1,2,3-triazolyl ester of ketorolac (15K) to be a novel allosteric modulator of the oncogenic kinase PAK1.
Shahinozzaman M; Ahmed S; Emran R; Tawata S
Sci Rep; 2021 Sep; 11(1):17471. PubMed ID: 34471161
[TBL] [Abstract][Full Text] [Related]
5. A computational approach to explore and identify potential herbal inhibitors for the p21-activated kinase 1 (PAK1).
Shahinozzaman M; Ishii T; Ahmed S; Halim MA; Tawata S
J Biomol Struct Dyn; 2020 Aug; 38(12):3514-3526. PubMed ID: 31448698
[TBL] [Abstract][Full Text] [Related]
6. Redesign of the PAK1 autoinhibitory domain for enhanced stability and affinity in biosensor applications.
Jha RK; Wu YI; Zawistowski JS; MacNevin C; Hahn KM; Kuhlman B
J Mol Biol; 2011 Oct; 413(2):513-22. PubMed ID: 21888918
[TBL] [Abstract][Full Text] [Related]
7. Precise design of highly isoform-selective p21-activated kinase 4 inhibitors: computational insights into the selectivity mechanism through molecular dynamics simulation and binding free energy calculation.
Su Y; Song P; Wang H; Hu B; Wang J; Cheng MS
J Biomol Struct Dyn; 2020 Aug; 38(13):3825-3837. PubMed ID: 31490101
[TBL] [Abstract][Full Text] [Related]
8. Identification of Pak1 inhibitors using water thermodynamic analysis.
Biswal J; Jayaprakash P; Suresh Kumar R; Venkatraman G; Poopandi S; Rangasamy R; Jeyaraman J
J Biomol Struct Dyn; 2020 Jan; 38(1):13-31. PubMed ID: 30661460
[TBL] [Abstract][Full Text] [Related]
9. Anti-cancer effect of novel PAK1 inhibitor via induction of PUMA-mediated cell death and p21-mediated cell cycle arrest.
Woo TG; Yoon MH; Hong SD; Choi J; Ha NC; Sun H; Park BJ
Oncotarget; 2017 Apr; 8(14):23690-23701. PubMed ID: 28423593
[TBL] [Abstract][Full Text] [Related]
10. Old drug new tricks: Chlorhexidine acts as a potential allosteric inhibitor toward PAK1.
Huang HW; Zhang XY; Song PL; Jiang HL; Li W; Wang PL; Wang J; Liu FN
Biochem Biophys Res Commun; 2018 Jan; 495(1):728-732. PubMed ID: 29146188
[TBL] [Abstract][Full Text] [Related]
11. An allosteric kinase inhibitor binds the p21-activated kinase autoregulatory domain covalently.
Viaud J; Peterson JR
Mol Cancer Ther; 2009 Sep; 8(9):2559-65. PubMed ID: 19723886
[TBL] [Abstract][Full Text] [Related]
12. Hair Growth Promoting and Anticancer Effects of p21-activated kinase 1 (PAK1) Inhibitors Isolated from Different Parts of Alpinia zerumbet.
Taira N; Nguyen BC; Tawata S
Molecules; 2017 Jan; 22(1):. PubMed ID: 28098826
[TBL] [Abstract][Full Text] [Related]
13. Targeting p21 activated kinase 1 (Pak1) to PAKup Pancreatic Cancer.
Jagadeeshan S; Venkatraman G; Rayala SK
Expert Opin Ther Targets; 2016 Nov; 20(11):1283-1285. PubMed ID: 27654702
[No Abstract] [Full Text] [Related]
14. Design, synthesis and biological evaluation of 2-indolinone derivatives as PAK1 inhibitors in MDA-MB-231 cells.
Yao D; Ruhan A; Jiang J; Huang J; Wang J; Han W
Bioorg Med Chem Lett; 2020 Sep; 30(17):127355. PubMed ID: 32738980
[TBL] [Abstract][Full Text] [Related]
15. Water Mapping and Scoring Approaches to Predict the Role of Hydration Sites in the Binding Affinity of PAK1 Inhibitors.
Biswal J; Jayaprakash P; Rayala SK; Venkatraman G; Rangasamy R; Poopandi S; Jeyakanthan J
Comb Chem High Throughput Screen; 2022; 25(4):660-676. PubMed ID: 33687876
[TBL] [Abstract][Full Text] [Related]
16. Investigation on the clinical efficacy and mechanism of compound kushen injection in treating esophageal cancer based on multi-dimensional network meta-analysis and in vitro experiment.
Zhou W; Huang Z; Wu C; Lu S; Fu C; Ye P; Tan Y; Wu Z; Fan X; Zhang J; Guo S; Jia S; Stalin A; Wang H; Zhang X; Wang M; Wu J
J Ethnopharmacol; 2021 Oct; 279():114386. PubMed ID: 34224810
[TBL] [Abstract][Full Text] [Related]
17. Why an A-loop phospho-mimetic fails to activate PAK1: understanding an inaccessible kinase state by molecular dynamics simulations.
Ng YW; Raghunathan D; Chan PM; Baskaran Y; Smith DJ; Lee CH; Verma C; Manser E
Structure; 2010 Jul; 18(7):879-90. PubMed ID: 20637424
[TBL] [Abstract][Full Text] [Related]
18. Identification of allosteric inhibitors of p21-activated kinase.
Viaud J; Peterson JR
Methods Mol Biol; 2012; 928():67-79. PubMed ID: 22956134
[TBL] [Abstract][Full Text] [Related]
19. Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening.
Li C; Zhang X; Zhang N; Zhou Y; Sun G; Zhao L; Zhong R
Molecules; 2020 Jan; 25(1):. PubMed ID: 31935979
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics exploration of PAK1 (P21-activated kinase-1) revealed potential network gene elements in breast invasive carcinoma.
Yellapu NK; Pulaganti M; Pakala SB
J Biomol Struct Dyn; 2017 Aug; 35(10):2269-2279. PubMed ID: 27456030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
